Bio-Medical Applications Of Rhode Island is a medicare approved dialysis facility center in Lincoln, Rhode Island and it has 16 dialysis stations. It is located in Providence county at 622 George Washington Highway, Lincoln, RI, 02865. You can reach out to the office of Bio-Medical Applications Of Rhode Island at (401) 333-4727. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applications Of Rhode Island has the following ownership type - Non-Profit. It was first certified by medicare in January, 2018. The medicare id for this facility is 412515 and it accepts patients under medicare ESRD program.
| Name | Bio-Medical Applications Of Rhode Island |
|---|---|
| Location | 622 George Washington Highway, Lincoln, Rhode Island |
| No. of Dialysis Stations | 16 |
| Medicare ID | 412515 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Non-Profit |
| Late Shifts | No |
| 622 George Washington Highway, Lincoln, Rhode Island, 02865 | |
| (401) 333-4727 | |
| Not Available |
News Archive
A major international study coordinated from Adelaide, South Australia has shown that treating pregnant women who develop mild gestational (pregnancy-related) diabetes helps their babies and improves the mother's health-related quality of life without increasing the risk of caesarean section.
The antidepressant drug duloxetine, known commercially as Cymbalta, helped relieve painful tingling feelings caused by chemotherapy in 59 percent of patients, a new study finds. This is the first clinical trial to find an effective treatment for this pain.
Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Aspect Medical Systems, Inc. ("Aspect Medical" or the "Company") (Nasdaq:ASPM), related to the Company's agreement to be acquired by Covidien plc ("Covidien") in a cash transaction valued at approximately $210 million, net of cash and short-term investments acquired.
The surface of your skin, called the epidermis, is a complex mixture of many different cell types - each with a very specific job. The production, or differentiation, of such a sophisticated tissue requires an immense amount of coordination at the cellular level, and glitches in the process can have disastrous consequences. Now, researchers at the Stanford University School of Medicine have identified a master regulator of this differentiation process.
› Verified 3 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.